Skip to content
Longterm Wiki
grant

Eradivir — Influenza Antiviral Drug

Metadata

Source Tablegrants
Source IDTHQJmrLMYh
Descriptionto Eradivir, $1,000,000, 2023-07
Source URLcoefficientgiving.org/grants/
ParentULjDXpSLCI
Children
CreatedMar 12, 2026, 5:54 AM
UpdatedMar 19, 2026, 8:57 PM
SyncedMar 19, 2026, 8:57 PM

Record Data

idTHQJmrLMYh
organizationIdCoefficient Giving(organization)
granteeIdEradivir
orgEntityIdCoefficient Giving(organization)
orgDisplayName
granteeEntityId
granteeDisplayNameEradivir
nameEradivir — Influenza Antiviral Drug
amount1000000
currencyUSD
period
date2023-07
status
sourcecoefficientgiving.org/funds/
notes[Biosecurity & Pandemic Preparedness] Open Philanthropy recommended an investment of $1,000,000 in Eradivir to support the development of an influenza antiviral drug. The team’s novel antiviral approach links two haptens that recruit the immune system to an already approved influenza antiviral, zana
programIdIVKWfIkgOz
dataSourceId

Source Check Verdicts

confirmed95% confidence

Last checked: 4/9/2026

[deterministic-row-match] Deterministic match: grantee, amount, date matched in source snapshot (2714 rows)

Debug info

Thing ID: THQJmrLMYh

Source Table: grants

Source ID: THQJmrLMYh